Home/Filings/4/0001213900-25-018889
4//SEC Filing

Romness Paul A. 4

Accession 0001213900-25-018889

CIK 0001795091other

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 6:03 PM ET

Size

5.6 KB

Accession

0001213900-25-018889

Insider Transaction Report

Form 4
Period: 2025-02-28
Romness Paul A.
DirectorPresident and CEO10% Owner
Transactions
  • Other

    Common Stock, par value $0.001 per share

    2025-02-28+225,0002,473,000 total
Footnotes (1)
  • [F1]Pursuant to a Transfer Agreement, effective as of May 13, 2024 (the "Transfer Agreement"), between Einodmil LLC ("Einodmil") and the reporting person, 600,000 shares of the issuer's common stock owned by the reporting person were placed in escrow in exchange for Einodmil's participation in a pre-IPO lock-up agreement. The Transfer Agreement, entered into in connection with the issuer's initial public offering, outlined conditions for distributing the 600,000 shares after expiration of the lock-up period, based on the 20-day VWAP of the issuer's common stock. On February 28, 2025, 225,000 of these shares were released from escrow and transferred to the reporting person. The remaining 375,000 shares were released from escrow and transferred to Einodmil.

Documents

1 file

Issuer

OS Therapies Inc

CIK 0001795091

Entity typeother

Related Parties

1
  • filerCIK 0001974517

Filing Metadata

Form type
4
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:03 PM ET
Size
5.6 KB